These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35768468)

  • 41. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The membrane protein KCNQ1 potassium ion channel: Functional diversity and current structural insights.
    Dixit G; Dabney-Smith C; Lorigan GA
    Biochim Biophys Acta Biomembr; 2020 May; 1862(5):183148. PubMed ID: 31825788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and functional changes in a synthetic S5 segment of KvLQT1 channel as a result of a conserved amino acid substitution that occurs in LQT1 syndrome of human.
    Verma R; Ghosh JK
    Biochim Biophys Acta; 2010 Mar; 1798(3):461-70. PubMed ID: 20044973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long QT syndrome: ionic basis and arrhythmia mechanism in long QT syndrome type 1.
    Sanguinetti MC
    J Cardiovasc Electrophysiol; 2000 Jun; 11(6):710-2. PubMed ID: 10868746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin suppresses IKs (KCNQ1/KCNE1) currents, which require β-subunit KCNE1.
    Wu M; Obara Y; Norota I; Nagasawa Y; Ishii K
    Pflugers Arch; 2014 May; 466(5):937-46. PubMed ID: 24068254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The therapeutic potential of neuronal KCNQ channel modulators.
    Gribkoff VK
    Expert Opin Ther Targets; 2003 Dec; 7(6):737-48. PubMed ID: 14640909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.
    Jons C; O-Uchi J; Moss AJ; Reumann M; Rice JJ; Goldenberg I; Zareba W; Wilde AA; Shimizu W; Kanters JK; McNitt S; Hofman N; Robinson JL; Lopes CM
    Sci Transl Med; 2011 Mar; 3(76):76ra28. PubMed ID: 21451124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1.
    Yang T; Smith JA; Leake BF; Sanders CR; Meiler J; Roden DM
    Mol Pharmacol; 2013 Feb; 83(2):481-9. PubMed ID: 23193163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome.
    Neyroud N; Richard P; Vignier N; Donger C; Denjoy I; Demay L; Shkolnikova M; Pesce R; Chevalier P; Hainque B; Coumel P; Schwartz K; Guicheney P
    Circ Res; 1999 Feb; 84(3):290-7. PubMed ID: 10024302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel.
    Tinel N; Diochot S; Borsotto M; Lazdunski M; Barhanin J
    EMBO J; 2000 Dec; 19(23):6326-30. PubMed ID: 11101505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The S4-S5 linker of KCNQ1 channels forms a structural scaffold with the S6 segment controlling gate closure.
    Labro AJ; Boulet IR; Choveau FS; Mayeur E; Bruyns T; Loussouarn G; Raes AL; Snyders DJ
    J Biol Chem; 2011 Jan; 286(1):717-25. PubMed ID: 21059661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome.
    Sesti F; Goldstein SA
    J Gen Physiol; 1998 Dec; 112(6):651-63. PubMed ID: 9834138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activation.
    Wu D; Delaloye K; Zaydman MA; Nekouzadeh A; Rudy Y; Cui J
    J Gen Physiol; 2010 Jun; 135(6):595-606. PubMed ID: 20479111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome.
    Yamaguchi M; Shimizu M; Ino H; Terai H; Hayashi K; Kaneda T; Mabuchi H; Sumita R; Oshima T; Hoshi N; Higashida H
    Clin Sci (Lond); 2005 Feb; 108(2):143-50. PubMed ID: 15500450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
    Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
    Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.
    Chen S; Zhang L; Bryant RM; Vincent GM; Flippin M; Lee JC; Brown E; Zimmerman F; Rozich R; Szafranski P; Oberti C; Sterba R; Marangi D; Tchou PJ; Chung MK; Wang Q
    Clin Genet; 2003 Apr; 63(4):273-82. PubMed ID: 12702160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A novel KCNQ1 mutation in Chinese with congenital long QT syndrome].
    Liang L; Du ZD; Cai LL; Wu JX; Zheng T; Qi TX
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):724-7. PubMed ID: 14731347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of abnormal trafficking of KCNE1 in long QT syndrome 5.
    Harmer SC; Tinker A
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1074-6. PubMed ID: 17956282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis of slow activation gating in the cardiac I Ks channel complex.
    Strutz-Seebohm N; Pusch M; Wolf S; Stoll R; Tapken D; Gerwert K; Attali B; Seebohm G
    Cell Physiol Biochem; 2011; 27(5):443-52. PubMed ID: 21691061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A hERG mutation E1039X produced a synergistic lesion on I
    Wu J; Mizusawa Y; Ohno S; Ding WG; Higaki T; Wang Q; Kohjitani H; Makiyama T; Itoh H; Toyoda F; James AF; Hancox JC; Matsuura H; Horie M
    Sci Rep; 2018 Feb; 8(1):3129. PubMed ID: 29449639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.